Norris Medicines Appoints Iqubal Ismail Patel as CFO and KMP
Norris Medicines Limited appointed Iqubal Ismail Patel as Chief Financial Officer and Key Managerial Personnel effective July 30, 2026, with Board approval granted on the same date following recommendations from the Audit Committee and Nomination and Remuneration Committee. Patel, a Graduate with over 11 years of association with the company, brings expertise in finance, accounts, taxation, budgeting, and financial planning, ensuring continuity in the company's financial strategy and governance.
*this image is generated using AI for illustrative purposes only.
Norris Medicines Limited appointed Iqubal Ismail Patel as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective July 30, 2026. The Board of Directors approved the appointment during a meeting held on July 30, 2026, acting on recommendations from both the Audit Committee and the Nomination and Remuneration Committee. The appointment was made pursuant to Section 203 of the Companies Act, 2013 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 5:00 PM and concluded at 5:30 PM on July 30, 2026. Norris Medicines Limited submitted the disclosure to BSE Limited, citing compliance with SEBI Circular Ref. No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Appointment Details
Patel's term of appointment is subject to terms and conditions, including remuneration, to be mutually agreed upon between him and the Board of Directors. He is not related to any existing Directors or Key Managerial Personnel of the company. The filing confirms that Patel is not debarred from holding office by virtue of any SEBI Order or other authority, nor is he disqualified under Section 164 of the Companies Act, 2013.
| Detail: | Information |
|---|---|
| Name: | Iqubal Ismail Patel |
| Designation: | Chief Financial Officer and KMP |
| Effective Date: | July 30, 2026 |
| Term: | As mutually agreed between Patel and the Board |
| Relationship Disclosure: | Not related to any Directors or KMPs |
Candidate Profile
Iqubal Ismail Patel holds a Graduate degree and has been associated with Norris Medicines Limited for more than 11 years. His experience spans finance, accounts, taxation, budgeting, financial planning, and corporate management. According to the filing, he has played a significant role in the company's financial operations and strategic initiatives in the past. His long-standing association with the organization suggests continuity in financial strategy rather than a shift in direction. With over a decade of internal experience, Patel is positioned to manage financial planning and corporate governance matters, bringing deep familiarity with the company's operational framework and regulatory history.
Historical Stock Returns for Norris Medicines
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -4.35% | -4.65% | +17.03% | -9.36% | +68.28% |
How might Iqubal Ismail Patel's internal promotion signal the company's strategy regarding financial continuity versus seeking external innovation?
What specific financial targets or restructuring initiatives is Norris Medicines expected to prioritize under Patel's new CFO leadership?
Will this appointment influence investor confidence in Norris Medicines' upcoming quarterly earnings and long-term valuation metrics?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
